![]() |
Elisabeth |
|
Information |
||
![]() |
Laboratoire d'Innovation Moléculaire et Applications (LIMA) | |
![]() |
Team "bio(IN)organic & medicinal chemistry" | |
![]() |
Strasbourg | |
![]() |
0000-0001-7026-4034 | |
![]() |
Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser. | |
![]() |
http://lima.unistra.fr/cbm/ | |
![]() |
@redoxLCBM | |
Scientific interests and projects |
||
The spread of drug resistance in parasites jeopardises recent progress to fight malaria. Chagas’ disease and schistosomiasis are neglected tropical parasitic diseases that are considered as public health top priorities. The expertise of the research team in redox medicinal chemistry is applied to the synthesis of ‘subversive substrates’ of NAD(P)H-dependent oxidoreductases, with the aim to develop antiparasitic agents and to identify new therapeutic targets. Our interdisciplinary activity spans from the synthesis (inhibitors, redox-cyclers, metabolites, ratiometric fluorescent probes sensitive to pH and redox gradients, labelled tools for metabol- & proteo-omics) to enzymology and understanding of the mechanisms of action in living parasites. Among our recent major achievements, we showed that, depending on their chemical substitution pattern, 3-benzyl-menadione derivatives, displayed potent antiparasitic activities, both in vitro and in vivo, against Plasmodium spp., Trypanosoma cruzi, or Schistosoma mansoni worms, induced specific phenotypic effects, with no obvious sign of toxicity in mice and in G6PD-deficient red blood cells. Our efforts are focused on the optimization of three early leads: the antimalarial plasmodione, a fast acting and transmission blocking agent, the anti-Chagas cruzidione, and the antischistosomal schistodiones. The goal of future collaborative research in ParaFrap is to optimize both early leads and synergistic partners for each disease model, to improve their pharmacokinetic properties and respective antiparasitic activities, to identify the sensitive parasite stages, their modes of action, and to validate the antiparasitic properties of the optimized compounds in vivo and with field parasite isolates. Our overarching aim is i) to select drug-candidates ready for further clinical development, ii) to unravel the modes of action through physicochemical approaches describing the interactions of antiparasitic agents with relevant targets. |
||
Top 5 publications of the last 5 years |
||
1. Feng L., Lanfranchi D. A., Cotos-Munoz L., Cesar Rodo E., Ehrhardt K., Goetz, A.-A., Zimmerman H., Fenaille F., Blandin S., Davioud-Charvet E. (2018) Synthesis of plasmodione metabolites and 13C-enriched plasmodione as chemical tools for drug metabolism investigation. Org. Biomol. Chem. 16, 2647 - 2665. doi: 10.1039/C8OB00227D 2. Krieg R., Jortzik E., Goetz A.-A., Blandin S., Wittlin S., Elhabiri M., Rahbari M., Nuryyeva S., Voigt K., Dahse H.-M., Brakhage A., Beckmann S., Quack T., Grevelding C. G., Pinkerton A. B., Schönecker B., Burrows J., Davioud-Charvet E.,Rahlfs S., Becker K. (2017) Arylmethylamino steroids as novel antiparasitic agents. Nat. Commun. 8:14478. Erratum : Nat Commun. 2019, 10:2997. doi:10.1038/s41467-019-11018-x 3. Ehrhardt, K., Deregnaucourt, C., Goetz, A.-A., Tzanova, T., Pradines, B., Adjalley, S. H., Blandin, S., Bagrel, D., Lanzer, M., Davioud-Charvet, E. (2016) The redox-cycler plasmodione is a fast acting antimalarial lead compound with pronounced activity against sexual and early asexual blood-stage parasites. Antimicrob. Agents Chemother. 60, 5146- 58. doi: 10.1128/AAC.02975-15 4. Cesar Rodo E., Feng L., Jida, M., Ehrhardt K., Bielitza M., Boilevin J., Lanzer M., Williams D. L., Lanfranchi, D. A., Davioud-Charvet, E. (2016) A platform of regioselective methodologies to access to polysubstituted 2-methyl-1,4-naphthoquinones derivatives: scope and limitations. Eur. J. Org. Chem. 11, 1982–1993. doi: 10.1002/ejoc.201600144 5. Bielitza, M., Belorgey, D., Ehrhardt, K., Johann, L., Lanfranchi, D. A., Gallo, V., Schwarzer, E., Mohring, F., Jortzik, E., Williams, D. L., Becker, K., Arese, P., Elhabiri, M., Davioud- Charvet E. (2015) Antimalarial NADPH-consuming redox-cyclers as superior G6PD deficiency copycats. Antioxid. Redox Signal. 22, 1337-51. 10.1089/ars.2014.6047 |
Postdoc (M/F) Molecular and cell biology in Trypanosoma brucei A 24-month post-doctoral position starting on November 1st 2025 (or before) and funded by the French National Research Agency (ANR) is available in the...
Postdoc (M/F) in molecular biology in P. falciparum Workplace: MONTPELLIER Contract Period: 24 months Expected date of employment: 1 October 2025 Proportion of work: Full Time Remuneration: Starting from...
Registration is now open for the EMBO Workshop "Host-Parasite Relationship: From Mechanisms to Control Strategies," supported by...
Maître de Conférences : Biologie et parasitologie animale – Interactions hôte-pathogène, Bordeaux, France Profil Pédagogique Le candidat enseignera la biologie animale, en particulier la diversité des...
The EMBO Workshop "Host-parasite relationship: from mechanisms to control strategies", supported by ParaFrap, will take place from...
ParaFrap Webinar Thursday, February 13, 2025 at 15:00 (CET) Gretchen...
Two PostDoc positions on Trypanosoma brucei and its interactions with blood vessels, Lisbon, Portugal A collaborative project in the Lisbon area, Portugal, to explore groundbreaking interactions between...
Postdoctoral position, Institut Pasteur, Paris, France A 24-month post-doctoral position starting on March 1st 2025 and funded by the French National Research Agency (ANR) is available in the Trypanosome...
Postdoctoral positions, LPHI Lab, Montpellier, France Two ERC-funded (JANUS 2024-2029) postdoc positions are open in the lab to study cell cycle regulation in malaria...
Postdoctoral position, Institut Pasteur, Paris, France A postdoc position is available at the Institut Pasteur Paris, in the signalling and host-parasite interactions research group, headed by Dr Najma Rachidi...
Actualités du LabEx
Autres actualités
Project Manager: Yoann MILLERIOUX
Contact
![]() |
@parafrap.bsky.social |
© 2023. Tous droits réservés by MLCOM
Notre site LabEx ParaFrap utilise des cookies pour réaliser des statistiques de visites, partager des contenus sur les réseaux sociaux et améliorer votre expérience. En refusant les cookies, certains services seront amenés à ne pas fonctionner correctement. Nous conservons votre choix pendant 30 jours. Vous pouvez changer d'avis en cliquant sur le bouton 'Cookies' en bas à gauche de chaque page de notre site. En savoir plus
Ce site utilise des cookies pour assurer son bon fonctionnement et ne peuvent pas être désactivés de nos systèmes. Nous ne les utilisons pas à des fins publicitaires. Si ces cookies sont bloqués, certaines parties du site ne pourront pas fonctionner.
Ce site utilise des cookies de mesure et d’analyse d’audience, tels que Google Analytics et Google Ads, afin d’évaluer et d’améliorer notre site internet.
Ce site utilise des composants tiers, tels que NotAllowedScript68568c0cd31eaReCAPTCHA, Google NotAllowedScript68568c0cd2e67Maps, MailChimp ou Calameo, qui peuvent déposer des cookies sur votre machine. Si vous décider de bloquer un composant, le contenu ne s’affichera pas
Des plug-ins de réseaux sociaux et de vidéos, qui exploitent des cookies, sont présents sur ce site web. Ils permettent d’améliorer la convivialité et la promotion du site grâce à différentes interactions sociales.
Ce site web utilise un certain nombre de cookies pour gérer, par exemple, les sessions utilisateurs.